MENU

GPCR Structure Therapeutics Forecast, Technical & Fundamental Analysis

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs... Show more

GPCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
GPCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

GPCR is expected to report earnings to rise 8.57% to -37 cents per share on November 18

Structure Therapeutics GPCR Stock Earnings Reports
Q3'26
Est.
$-0.38
Q1'26
Est.
$-0.35
Q4'25
Beat
by $0.45
Q3'25
Missed
by $0.10
Q2'25
Missed
by $0.10
The last earnings report on May 07 showed earnings per share of -34 cents, meeting the estimate of -34 cents. With 677.69K shares outstanding, the current market capitalization sits at 2.75B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
601 Gateway Boulevard
Phone
+1 650 457-1978
Employees
220
Web
https://www.structuretx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IDVY27.040.49
+1.84%
First Trust International Ris Div AchETF
DIVI44.120.43
+0.98%
Franklin Intl Core Div Tlt Idx ETF
BBH229.390.76
+0.33%
VanEck Biotech ETF
SIFI42.71N/A
N/A
Harbor Ares Systematic Mltsct Inc ETF
FTRI18.24-0.02
-0.08%
First Trust Indxx Glbl Natrl Res Inc ETF

GPCR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been loosely correlated with WVE. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if GPCR jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
-2.25%
WVE - GPCR
64%
Loosely correlated
-1.71%
KYMR - GPCR
62%
Loosely correlated
-1.74%
NRIX - GPCR
45%
Loosely correlated
-2.75%
OCUL - GPCR
42%
Loosely correlated
-1.22%
FULC - GPCR
40%
Loosely correlated
N/A
More
Structure Therapeutics (GPCR) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com